Indian pharma companies’ revenue expected to moderate to 9-11% in FY25 vs 13-14% in FY24

Indian pharma companies’ revenue expected to moderate to 9-11% in FY25 vs 13-14% in FY24

ANI |
Updated: Sep 30, 2024 16:01 IST

New Delhi [India], September 30 (ANI): Revenues of Indian pharma companies are likely to expand by 9-11 per cent in the current financial year, albeit a moderation from the increase of 13-14 per cent recorded in the previous year, said rating agency ICRA in a report.This projected revenue, as per the rating agency, will be driven by 9-11…
Read More…

Source: https://www.aninews.in/news/business/indian-pharma-companies-revenue-expected-to-moderate-to-9-11-in-fy25-vs-13-14-in-fy2420240930160106/